Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $228 | In Stock | |
| 5 mg | $579 | In Stock | |
| 10 mg | $928 | In Stock | |
| 25 mg | $1,370 | In Stock | |
| 50 mg | $1,850 | In Stock | |
| 100 mg | $2,480 | In Stock | 
| Description | Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.  | 
| Molecular Weight | 146.48 kDa | 
| Cas No. | 1660159-36-3 | 
| Color | Transparent | 
| Appearance | Liquid | 
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.